Radiation therapy in association with cisplatin-based chemotherapy or cetuximab, a monoclonal anti-epidermal growth factor receptor (EGFR) antibody, is the cornerstone of locally advanced head and neck cancers (HNC), the concurrent treatment demonstrating a synergistic potential. This evidence concerns the gene EGFR and head and neck cancer.